國立虎尾科技大學 |

Drug-Induced Lung Injury

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Drug-Induced Lung Injury/ edited by Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba.
other author:	Hanaoka, Masayuki.
Description:	VIII, 215 p. 53 illus., 15 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Respiratory organs—Diseases. -
Online resource:	https://doi.org/10.1007/978-981-10-4466-3
ISBN:	9789811044663

Drug-Induced Lung Injury
Drug-Induced Lung Injury[electronic resource] /edited by Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba. - 1st ed. 2018. - VIII, 215 p. 53 illus., 15 illus. in color.online resource. - Respiratory Disease Series: Diagnostic Tools and Disease Managements,2509-5552. - Respiratory Disease Series: Diagnostic Tools and Disease Managements,.

Part I　Definition, Pathogenesis, and Epidemiology -- 1. Definition, Pathogenesis and Epidemiology: What is DLI? -- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI? -- 3. Clinical Characteristics of DLI: What are the clinical features of DLI? -- Part II　Diagnosis -- 4. Diagnostic Approach for DLI: How is DLI diagnosed? -- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI? -- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted? -- 7. Pathology of DLI: What is the pathological significance of DLI? -- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI? -- Part II　Treatment -- 9. Therapeutic Strategies for DLI: How should DLI be treated? -- Part IV　Drugs Causing DLI -- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs? -- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs? -- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs? -- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines? -- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs?.

This book covers various aspects of a respiratory system disorder associated with prescribed drugs that do not yet have established treatment guidelines, and for which the only treatment is to discontinue taking the drug. Very little clinical evidence regarding the disorder is available, since randomized trials cannot to be carried out, the onset of the disorder cannot be predicted, and the resulting pathological condition is life-threatening. However, the need for an established treatment continues to grow due to the introduction of many new drugs, such as anti-neoplastic drugs, biological products, and molecular target drugs, the adverse effects of which are difficult to differentiate from those of other lung diseases, such as lung infectious diseases. Drug-Induced Lung Injury offers a highly beneficial resource not only for respiratory physicians but also all medical clinicians who prescribe drugs, nurses, pharmacists and pharmaceutical scientists. Written by pioneering experts in the field, the book examines a wealth of cases and the insights they yield concerning the diagnosis, treatment and specific drugs causing the disease. It not only fosters a deeper understanding of the disorder but also highlights the current challenges and paves the way for future clinical research.

ISBN: 9789811044663

Standard No.: 10.1007/978-981-10-4466-3doiSubjects--Topical Terms:

1254083
Respiratory organs—Diseases.

LC Class. No.: RC705-779

Dewey Class. No.: 616.2

Drug-Induced Lung Injury
LDR:04296nam a22004095i 4500 001 992531
003 DE-He213
005 20200702002217.0
007 cr nn 008mamaa
008 201225s2018 si | s |||| 0|eng d
020 $a 9789811044663 $9 978-981-10-4466-3
024 7 $a 10.1007/978-981-10-4466-3 $2 doi
035 $a 978-981-10-4466-3
050 4 $a RC705-779
072 7 $a MJL $2 bicssc
072 7 $a MED079000 $2 bisacsh
072 7 $a MJL $2 thema
082 0 4 $a 616.2 $2 23
245 1 0 $a Drug-Induced Lung Injury $h [electronic resource] / $c edited by Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba.
250 $a 1st ed. 2018.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2018.
300 $a VIII, 215 p. 53 illus., 15 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Respiratory Disease Series: Diagnostic Tools and Disease Managements, $x 2509-5552
505 0 $a Part I　Definition, Pathogenesis, and Epidemiology -- 1. Definition, Pathogenesis and Epidemiology: What is DLI? -- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI? -- 3. Clinical Characteristics of DLI: What are the clinical features of DLI? -- Part II　Diagnosis -- 4. Diagnostic Approach for DLI: How is DLI diagnosed? -- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI? -- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted? -- 7. Pathology of DLI: What is the pathological significance of DLI? -- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI? -- Part II　Treatment -- 9. Therapeutic Strategies for DLI: How should DLI be treated? -- Part IV　Drugs Causing DLI -- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs? -- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs? -- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs? -- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines? -- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs?.
520 $a This book covers various aspects of a respiratory system disorder associated with prescribed drugs that do not yet have established treatment guidelines, and for which the only treatment is to discontinue taking the drug. Very little clinical evidence regarding the disorder is available, since randomized trials cannot to be carried out, the onset of the disorder cannot be predicted, and the resulting pathological condition is life-threatening. However, the need for an established treatment continues to grow due to the introduction of many new drugs, such as anti-neoplastic drugs, biological products, and molecular target drugs, the adverse effects of which are difficult to differentiate from those of other lung diseases, such as lung infectious diseases. Drug-Induced Lung Injury offers a highly beneficial resource not only for respiratory physicians but also all medical clinicians who prescribe drugs, nurses, pharmacists and pharmaceutical scientists. Written by pioneering experts in the field, the book examines a wealth of cases and the insights they yield concerning the diagnosis, treatment and specific drugs causing the disease. It not only fosters a deeper understanding of the disorder but also highlights the current challenges and paves the way for future clinical research.
650 0 $a Respiratory organs—Diseases. $3 1254083
650 1 4 $a Pneumology/Respiratory System. $3 668561
700 1 $a Hanaoka, Masayuki. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1284229
700 1 $a Nakamura, Hiroyuki. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1103255
700 1 $a Aoshiba, Kazutetsu. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1103256
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811044656
776 0 8 $i Printed edition: $z 9789811044670
776 0 8 $i Printed edition: $z 9789811351464
830 0 $a Respiratory Disease Series: Diagnostic Tools and Disease Managements, $x 2509-5552 $3 1284230
856 4 0 $u https://doi.org/10.1007/978-981-10-4466-3
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)